Wyoming law restricts kratom sales and labels, lets health officials arrange store checks, and funds health and agriculture department work through June 2028.
People may not knowingly sell kratom products with certain ingredients, high levels of 7-hydroxymitragynine, child-appealing designs, or forms meant to be smoked or vaporized. Sales to people under 21 are barred too.
Each retail package must identify its maker or distributor, list ingredients, and give safety warnings and serving directions, including the amounts of two kratom compounds per serving.
The health department leads compliance and may support local agencies that check stores through random, unannounced inspections. After repeated violations, a court may temporarily stop sales at the location involved.
The law provides money for health department implementation and agriculture department testing, including one authorized full-time testing position and equipment.
People may not knowingly prepare, distribute, advertise, sell, or offer for sale kratom products that break the listed rules. These rules apply to people handling kratom products and to retailers that display or store them where people under 21 could access them. The rules cover adulterated products, products with more than 2% 7-hydroxymitragynine in the alkaloid composition, products made to appeal to children, and combustible or vaporized products. The law also bars sales to people under 21 and certain manufacture, packaging, distribution, or labeling involving synthesized or semi-synthesized alkaloids for people under 21. A violation is a misdemeanor punishable by up to one year in jail, a fine of up to $1,000, or both. A retailer may avoid a fine for a first offense in a 24-month period if it meets the listed written-policy, employee-information, age-check, and discipline requirements. These rules took effect July 1, 2026.
People who knowingly handle kratom products for sale must ensure each retail package has the required label. The requirement applies to each retail package of kratom products that a person knowingly prepares, distributes, delivers, advertises, sells, or offers for sale. The label must identify the manufacturer or distributor, list all ingredients, and give warnings about age, pregnancy, breastfeeding, health care advice, habit-forming use, and possible interactions with medicines or drugs. It must also include the required federal disclaimer, keep-away-from-children statement, and serving and alkaloid information. The labeling rule took effect July 1, 2026.
The Wyoming Department of Health leads compliance work and may arrange random, unannounced inspections of kratom retailers. The department works with local law enforcement and may authorize local agencies or other qualified local groups to inspect places that sell kratom products. The department may work with local agencies and may contract with or provide grants to authorized local agencies or groups for inspections. People under 21 may take part only with written consent; a minor also needs a parent's or guardian's written consent. Inspectors must stay within sight or sound, notify the store in writing after the inspection, and provide a report within two days. After a retailer's third or later violation within two years, the department or district attorney may ask a court to stop sales at the location where the violation occurred for up to 180 days. The court may grant the request if it finds the retailer may continue violating the law. The inspection and enforcement provisions took effect July 1, 2026. A court may order a sales ban of up to 180 days after a retailer's third or later violation within two years.
The law sets aside money for the health and agriculture departments to carry out its requirements. The appropriations support the Wyoming departments of Health and Agriculture, including agriculture's testing of kratom products. The health department receives $115,000 for implementation. The agriculture department is authorized one full-time testing position and receives $197,540 for its salary and benefits, plus $24,000 for testing equipment. The money comes from opioid settlement funds or, if those funds are unavailable for this purpose, the general fund. The appropriations cover July 1, 2026, through June 30, 2028.
No hearings or votes scheduled.